Assenagon Asset Management S.A. boosted its stake in shares of Tenet Healthcare Corporation (NYSE:THC - Free Report) by 118.6% during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 106,070 shares of the company's stock after buying an additional 57,537 shares during the period. Assenagon Asset Management S.A. owned approximately 0.13% of Tenet Healthcare worth $27,107,000 at the end of the most recent quarter.
Other institutional investors also recently bought and sold shares of the company. Manning & Napier Advisors LLC bought a new stake in shares of Tenet Healthcare during the second quarter worth $168,761,000. Arrowstreet Capital Limited Partnership increased its stake in shares of Tenet Healthcare by 57.4% during the first quarter. Arrowstreet Capital Limited Partnership now owns 671,700 shares of the company's stock valued at $126,757,000 after buying an additional 244,901 shares during the period. Bank of New York Mellon Corp bought a new stake in shares of Tenet Healthcare in the second quarter valued at about $106,342,000. Empowered Funds LLC raised its holdings in shares of Tenet Healthcare by 22.1% in the first quarter. Empowered Funds LLC now owns 284,753 shares of the company's stock valued at $53,736,000 after acquiring an additional 51,549 shares in the last quarter. Finally, Hsbc Holdings PLC increased its position in Tenet Healthcare by 3,478.7% during the 4th quarter. Hsbc Holdings PLC now owns 266,400 shares of the company's stock valued at $53,269,000 after purchasing an additional 258,956 shares during the period. 95.44% of the stock is currently owned by institutional investors.
Tenet Healthcare Trading Up 0.0%
Shares of Tenet Healthcare stock opened at $267.27 on Monday. The firm's 50 day simple moving average is $264.36 and its two-hundred day simple moving average is $219.29. The firm has a market capitalization of $21.52 billion, a price-to-earnings ratio of 10.31, a PEG ratio of 1.02 and a beta of 1.20. Tenet Healthcare Corporation has a 12-month low of $157.58 and a 12-month high of $283.05. The company has a current ratio of 1.41, a quick ratio of 1.35 and a debt-to-equity ratio of 2.00.
Tenet Healthcare (NYSE:THC - Get Free Report) last posted its quarterly earnings data on Thursday, July 23rd. The company reported $6.12 EPS for the quarter, topping the consensus estimate of $4.26 by $1.86. The business had revenue of $6.04 billion during the quarter, compared to the consensus estimate of $5.43 billion. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The business's revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $4.02 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. Analysts predict that Tenet Healthcare Corporation will post 21.04 EPS for the current year.
Insiders Place Their Bets
In other news, Director Nadja West sold 1,152 shares of the stock in a transaction on Wednesday, September 2nd. The shares were sold at an average price of $258.80, for a total value of $298,137.60. Following the sale, the director owned 23,653 shares in the company, valued at $6,121,396.40. This represents a 4.64% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Lisa Foo sold 24,000 shares of the firm's stock in a transaction on Monday, August 31st. The stock was sold at an average price of $266.32, for a total transaction of $6,391,680.00. Following the transaction, the executive vice president directly owned 8,053 shares of the company's stock, valued at approximately $2,144,674.96. This trade represents a 74.88% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 131,199 shares of company stock worth $35,065,587. Company insiders own 0.97% of the company's stock.
Analysts Set New Price Targets
Several equities research analysts have recently weighed in on the stock. Truist Financial upped their price target on shares of Tenet Healthcare from $270.00 to $290.00 and gave the stock a "buy" rating in a research report on Tuesday, July 28th. The Goldman Sachs Group reissued a "buy" rating and set a $305.00 price objective on shares of Tenet Healthcare in a report on Tuesday, July 28th. Barclays boosted their price objective on shares of Tenet Healthcare from $240.00 to $271.00 and gave the stock an "overweight" rating in a research note on Friday, July 24th. BMO Capital Markets began coverage on Tenet Healthcare in a research report on Tuesday, September 22nd. They set a "market perform" rating and a $265.00 price objective on the stock. Finally, Mizuho set a $290.00 price objective on shares of Tenet Healthcare in a research report on Monday, August 10th. Eighteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, Tenet Healthcare has a consensus rating of "Moderate Buy" and an average target price of $278.45.
Get Our Latest Stock Analysis on Tenet Healthcare
Tenet Healthcare Company Profile
(
Free Report)
Tenet Healthcare Corp. NYSE: THC is a diversified healthcare services company headquartered in Dallas, Texas. Through its hospital operations and outpatient platforms, the company provides a range of medical services to patients across the United States.
Tenet operates acute care and specialty hospitals, ambulatory surgery centers, imaging facilities and other outpatient care sites. Its United Surgical Partners International subsidiary is a major provider of ambulatory surgery services and partners with physicians and health systems.
Further Reading
Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Corporation (NYSE:THC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tenet Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tenet Healthcare wasn't on the list.
While Tenet Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.